Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


Allergies 2014

09 Jul 2014 - 10 Jul 2014 - London, UK



Bookmark and Share


Analyse industry developments and the future of allergy therapeutics

The launch event for Allergies is here and will be taking place on 9th July and 10th July 2014 in Central London. The market for Allergies is expected to reach $14.7 billion by 2015. As companies look to develop different compounds and antibodies to treat allergies, this event will mark the path forward in terms of allergies within personalised medicines and beyond.

We have worked in partnership with an expert advisory board which includes KOLs from Imperial College London, Swecure AB and GSK, to put together an exciting conference agenda.

The programme will examine key areas such as novel approaches in the treatment of allergy, therapeutic advances, allergic pathophysiology, current update on food allergies, the future of allergen-specific immunotherapy and challenges, allergy prevention, diagnosis and drug development plus much more. 

Reasons to Attend:

  • Key case study presentation from GSK on new therapeutic tools for allergies
  • Clinicians' perspective – advances in allergy diagnostics featuring Royal Free Hospital and Imperial College London
  • Allergy specialists – Dr Scadding and Dr Church present on new research and findings
  • Exclusive case study on the success of peanut allergy trials
  • Evaluate new breakthroughs in allergy treatment and gain understanding into guidance on development novel therapeutics
  • Analyse current and novel approaches of allergen-specific immunotherapy 

Key Speakers Include:

  • Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GSK
  • Professor Alf Lindberg, Chief Scientific Director, Swecure AB
  • Dr Rainer Henning, CEO, Biomay AG
  • Dr Donna Finch, Principal Scientist, MedImmune
  • Dr Glenis Scadding, Honorary Consultant Allergist & Rhinologist, Royal National Throat, Nose and Ear Hospital
  • Calman Prussin, Principal Investigator, National Institute of Allergy and Infectious Diseases(NIAID)
  • Professor Rudolf Valenta, Professor for Allergology, Medical University of Vienna

To register online or to download a brochure visit http://www.smi-online.co.uk/goto/allergies7.asp

Alternatively contact John Collins on +44 (0)20 7827 6734 or email jcollins@smi-online.co.uk




Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Genome of 6000-Year-Old Barley Sequenced
Researchers have successfully sequenced the genome of Chalcolithic barley grains for the first time.
3D Models May Yield Ovarian Cancer Insights
Researchers are developing new tools to decipher ovarian cancer developments through a 3D printing technology.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!